Back
Apellis Pharmaceuticals, Inc. Vs. Artivion, Inc. Industry Stock Comparison
Buy
56
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$25.31
Seasonality Move:
7.92%
Buy
62
AORT
Artivion, Inc.
Last Price:
$45.96
Seasonality Move:
4.7%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.56. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Artivion, Inc. (AORT)
is a Buy
Is Artivion, Inc. a Buy, Sell or Hold?
-
The current Artivion, Inc. [AORT] share price is $45.37. The Score for AORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
AORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
AORT Stock Price Chart
What is Artivion, Inc.'s stock price today?
-
The Artivion, Inc. share price today is $45.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AORT is experiencing slight buying pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 62.69 | Buy |
| Chaikin Money Flow: | -2410168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.51 - 23.45) | Buy |
| Bollinger Bands (100): | (20.9 - 26.98) | Buy |
AORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 52.45 | Buy |
| Chaikin Money Flow: | 62916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.4 - 46.36) | Sell |
| Bollinger Bands (100): | (38.2 - 46.24) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.1 | Buy |
| 20-day SMA: | 21.92 | Buy |
| 50-day SMA: | 23.12 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 24 | Buy |
| 20-day EMA: | 22.84 | Buy |
| 50-day EMA: | 22.8 | Buy |
| 200-day EMA: | 24.25 | Buy |
AORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.69 | Buy |
| 20-day SMA: | 45.19 | Buy |
| 50-day SMA: | 44.31 | Buy |
| 200-day SMA: | 34.7 | Buy |
| 8-day EMA: | 44.98 | Buy |
| 20-day EMA: | 45.07 | Buy |
| 50-day EMA: | 44.16 | Buy |
| 200-day EMA: | 37.26 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Artivion, Inc. Earnings Growth & AORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.21 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Artivion, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||